Clarity Act Supporters Add Ethics Rules to Save Senate Bill

0 Comments

Sen. Cynthia Lummis (R-Wyo.) released an amended draft of the Clarity Act on Wednesday (July 22), saying it includes a ban on federal officials issuing or sponsoring digital assets and that she aims to reach a deal with Democratic senators within days. It was reported July 17 that Democratic senators’ reservations around ethics issues and […]

House subcommittee probes Compass MRED private listing network

0 Comments

House subcommittee probes Compass MRED private listing network Skip to content © 2006-2026 HW Media, LLC. All rights reserved.Powered by WordPress VIP What’s New? Updated 1 hour ago Latest

Fujiyama Power Shares Soar 80% in Six Months; Is This the Next Solar Multibagger to Watch?

0 Comments

Stocks Published: Wednesday, July 22, 2026, 18:04 [IST] Fujiyama Power share price: Shares of Indian manufacturer of solar panels, Fujiyama Power, have seen a sharp rally over the past few months despite volatility across the Indian stock market. The solar energy stock has surged close to 80% in six months. Accelerating residential rooftop solar adoption, […]

SEC Announces Departure of Principal Deputy Director of Enforcement Sam Waldon

0 Comments

The Securities and Exchange Commission today announced that Sam Waldon, Principal Deputy Director of the Division of Enforcement, will depart the agency on July 31, 2026, after more than 14 years at the SEC. He will be succeeded as Principal Deputy Director by Osman Nawaz, who previously served with the SEC from 2010-2024 before rejoining […]

SEC Enforcement Deputy Director Sam Waldon to Leave Agency

0 Comments

Another leader at the Securities and Exchange Commission is stepping down, months after the departure of Enforcement Division Director Margaret Ryan. According to the commission, Enforcement Division Principal Deputy Director Sam Waldon will leave the agency at the end of this month after a lengthy tenure. In a statement, Chair Paul Atkins said he “personally […]

Bilt Rewards vs. Chase Ultimate Rewards: Which Wins?

0 Comments

Bilt Rewards and Chase Ultimate Rewards® both let you turn everyday spending into points you can redeem for travel at a set rate or transfer to frequent flyer and hotel loyalty programs, often with a chance to get more value. Chase has built its reputation with a broad lineup of travel cards, strong welcome bonuses […]

SpaceX shorts are betting $25 billion against Elon Musk. Is it time to cover?

0 Comments

SpaceX’s short position is a well-known fact by now. About 206 million SpaceX shares have been sold short, as per S3 Partners data. In fact, the number of bearish bets rose very fast —from about 185 million shares last week to around 40 million shares just a month ago. And currently, short positions account for […]

Discounted office space opening the door to multifamily conversions

0 Comments

Office space values have fallen so low that it is becoming more feasible for developers to convert a growing number of buildings to residential uses, according to research by CommercialCafe, a market analytics platform operated by Yardi Matrix, subsidiary of property management technology firm Yardi Systems. The report found that nearly half of all office […]

Which ETF Is Healthier for Your Portfolio: Vanguard Health Care ETF or iShares Pharmaceuticals ETF?

0 Comments

Vanguard Health Care ETF (VHT -0.70%) provides broad-based sector coverage with a significantly lower expense ratio, while iShares U.S. Pharmaceuticals ETF (IHE -0.30%) offers concentrated access to domestic drug companies. Both ETFs provide targeted healthcare exposure, but they differ significantly in scope and cost. While one drills down into the specific mechanics of drug development […]

Dr Reddy’s Q1 Results: Profit Slumps 69%, Revenue Declines as Semaglutide Disruption, Weak US Sales Weigh on

0 Comments

News Published: Wednesday, July 22, 2026, 23:06 [IST] Dr Reddy’s Laboratories reported a weak set of earnings for the first quarter of FY27, with profit declining sharply due to supply disruptions in its semaglutide business and continued pressure in the US market. The Hyderabad-based drugmaker said its consolidated net profit fell 69% year-on-year to Rs […]